[Increase of sulfobromophthalein clearance by phenothiazines].
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D004790:Enzyme Induction; D005260:Female; D005476:Fluphenazine / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D008111:Liver Function Tests; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy; D008728:Methotrimeprazine / Q000627:therapeutic use; D008875:Middle Aged; D010640:Phenothiazines / Q000627:therapeutic use; D013448:Sulfobromophthalein / Q000378:metabolism*; D013881:Thioridazine / Q000627:therapeutic use
D014150:Antipsychotic Agents; D010640:Phenothiazines; D013448:Sulfobromophthalein; D008728:Methotrimeprazine; D013881:Thioridazine; D005476:Fluphenazine
Augmentation de la clearance de la brome-sulfone-phtaléine par les phénothiazines.